» Articles » PMID: 32176071

Clinical Efficacy and Safety of Stem Cell Therapy for Knee Osteoarthritis: A Meta-analysis

Overview
Specialty General Medicine
Date 2020 Mar 17
PMID 32176071
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We performed a meta-analysis of the efficacy and safety of stem cell therapy as a clinical treatment of knee osteoarthritis. This meta-analysis is expected to provide evidence of the efficacy of stem cell therapy, which is currently controversial, as a conservative treatment for knee osteoarthritis.

Methods: An online search for relevant articles was conducted in the PubMed, EMBASE, and Cochrane Library databases. The search terms were "stem cells" and "osteoarthritis." We conducted a quality assessment of the included articles and extracted the following indicators: Visual Analogue Scale (VAS) score, Subjective International Knee Documentation Committee (IKDC) score, Western Ontario and McMaster Universities (WOMAC) subscales, and adverse events. The RevMan5.3 software was used for determining effect sizes.

Results: Nine randomized controlled trials involving 339 patients were included. VAS score and IKDC score from baseline to 24 months were improved in the stem cell therapy group compared to those in the control group. However, no significant difference was observed between the 2 groups in IKDC score changes from baseline to 6 and 12 months, as well as in WOMAC-Pain, WOMAC-Stiffness, and WOMAC-Physical Function score changes at each visit point.

Conclusion: Stem cell therapy is certainly superior to traditional treatments in the conservative treatment of KOA; it considerably reduces pain with no obvious additional side effects.

Citing Articles

Effects of muscle energy technique along conventional physical therapy after mesenchymal stem cell transplantation in knee osteoarthritis patients.

Ashraf F, Anwar K, Arshad H Pak J Med Sci. 2024; 40(11):2558-2564.

PMID: 39634887 PMC: 11613387. DOI: 10.12669/pjms.40.11.9605.


Intra-Articular Injection of Stem Cells for the Regeneration of Knee Joint Cartilage: a Therapeutic Option for Knee Osteoarthritis - a Narrative Review.

Lee H, Hossain R, Baek C, Lee C, Hwang S Biomol Ther (Seoul). 2024; 33(1):86-94.

PMID: 39632656 PMC: 11704397. DOI: 10.4062/biomolther.2024.139.


Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials.

Tabet C, Pacheco R, Martimbianco A, Riera R, Hernandez A, Bueno D J Orthop Translat. 2024; 48:176-189.

PMID: 39360004 PMC: 11445595. DOI: 10.1016/j.jot.2024.07.012.


Evaluation of the therapeutic potential of infrapatellar fat pad adipose-derived stem cells and their secretome for regenerating knee articular cartilage in a rat model of osteoarthritis.

Dalir S, Meimandi Parizi A, Tanideh N, Kian M, Nowzari F, Iraji A Iran J Vet Res. 2024; 25(1):33-40.

PMID: 39156795 PMC: 11327642. DOI: 10.22099/IJVR.2024.47870.6959.


Seven-Year Longitudinal Study: Clinical Evaluation of Knee Osteoarthritic Patients Treated with Mesenchymal Stem Cells.

Spasovski D, Spasovski V, Bascarevic Z, Stojiljkovic M, Andjelkovic M, Pavlovic S J Clin Med. 2024; 13(13).

PMID: 38999426 PMC: 11242523. DOI: 10.3390/jcm13133861.


References
1.
Wang D, Zhang H, Liang J, Li X, Feng X, Wang H . Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant. 2014; 22(12):2267-77. PMC: 11849135. DOI: 10.3727/096368911X582769c. View

2.
Murphy J, Dixon K, Beck S, Fabian D, Feldman A, Barry F . Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum. 2002; 46(3):704-13. DOI: 10.1002/art.10118. View

3.
Vangsness Jr C, Farr 2nd J, Boyd J, Dellaero D, Mills C, LeRoux-Williams M . Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am. 2014; 96(2):90-8. DOI: 10.2106/JBJS.M.00058. View

4.
Lazarus H, Koc O, Devine S, Curtin P, Maziarz R, Holland H . Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant. 2005; 11(5):389-98. DOI: 10.1016/j.bbmt.2005.02.001. View

5.
Juni P, Altman D, Egger M . Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ. 2001; 323(7303):42-6. PMC: 1120670. DOI: 10.1136/bmj.323.7303.42. View